Riskpilot← Back to searchSign inGet full accessCompleMedic ApS
APSActiveCVR 35403957Strandgården 91Research and experimental development on natural sciences and engineering · NACE 7210Est. 20131 employeeswww.complemedic.dk
Revenue 2024
DKK 66K
+43% vs 2023
EBITDA margin
100.0%
+43% vs 2023
Equity ratio
-86.4%
Financial strength
Net profit 2024
DKK 51K
+185% vs 2023
| Revenue | DKK 66K | +43% |
| EBITDA | DKK 66K | +43% |
| Net profit | DKK 51K | +185% |
| Total assets | DKK 237K | +258% |
| Equity | DKK -205K | +20% |
| Employees | 1 | — |
Legal name
CompleMedic ApS
CVR number
35403957
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
16. juli 2013
Share capital
DKK 120.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede direktion.
Company purpose
Selskabets formål er at udvikle, og sælge, plantebaserede
helseprodukter, herunder lotions med terapeutisk effekt samt til forebyggelse og
lindring af aldersrelaterede lidelser. Udvikling af produkterne kan omfatte
dokumentation af effekten samt eventuelle forbedringer af formuleringen.
Address
Strandgården 91
Phone
+4531190275
Email
flt@complemedic.dk
Website
www.complemedic.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -813 | -131 | -36 | 1.018 | -278 | -103 | -17 | -6 | 1 | 46 | 66 |
| Staff expenses | -0 | -21 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -813 | -153 | -36 | 1.018 | -278 | -103 | -17 | -6 | 1 | 46 | 66 |
| Depreciation & amort. | -0 | -7 | -7 | -21 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -813 | -160 | -43 | 997 | -278 | -103 | -17 | -6 | 1 | 46 | 66 |
| Net financials | -24 | -37 | -36 | 5 | -3 | -17 | 19 | -0 | -0 | -16 | 0 |
| Profit before tax | -837 | -196 | -79 | 1.002 | -281 | -121 | 2 | -6 | 1 | 30 | 67 |
| Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -83 | 90 | 16 |
| Net profit | -837 | -196 | -79 | 1.002 | -281 | -121 | 2 | -6 | 84 | -60 | 51 |
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 396 | 273 | 262 | 248 | 170 | 70 | 64 | 67 | 139 | 66 | 237 |
| Equity | -757 | -953 | -1.032 | 125 | -155 | -276 | -274 | -280 | -196 | -256 | -205 |
| Long-term debt | 1.124 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 28 | 1.226 | 1.294 | 123 | 326 | 346 | 339 | 347 | 335 | 322 | 442 |
| Total debt | 1.152 | 1.226 | 1.294 | 123 | 326 | 346 | 339 | 347 | 335 | 322 | 442 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20142024
Equity ratio
-86.4%
This company
38.2%
Market median
-326% vs market
20142024
Return on equity
5081900.0%
This company
18.4%
Market median
+27618922% vs market
20142024
Net profit margin
76.6%
This company
8.1%
Market median
+846% vs market
20142024
Asset turnover
0.28×
This company
1.12×
Market median
-75% vs market
20142024
Debt / equity
2.16×
This company
0.62×
Market median
-248% vs market
20142024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2013-07-16 – 2014-12-31
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2026 | |
| Individual | 15.0% | 15.0% | 2024 | |
STENLANDSDAL ApS | Company | 10.0% | 10.0% | 2024 |
OPE HOLDING ApS | Company | 10.0% | 10.0% | 2024 |
IdeaList ApS | Company | 33.3% | 33.3% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CompleMedic ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|